SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC Meeting Abstract
| Authors: | Nishio, M.; Negrao, M. V.; Arbour, K. C.; Burns, T. F.; Cappuzzo, F.; Dingemans, A. M. C.; Girard, N.; Gronberg, B. H.; Hochmair, M.; Leal, T.; Lindsay, C. R.; Lu, S.; Paz-Ares, L. G.; Reck, M.; Sabari, J. K.; Spira, A. I.; William, W. N. Jr; Chen, A.; Grul, C. M. V.; Peters, S. |
| Abstract Title: | SUNRAY-01, a pivotal, global study of olomorasib (LY3537982) in combination with pembrolizumab with or without chemotherapy for 1L treatment in KRAS G12C-mutant advanced NSCLC |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557406374 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.23_suppl.TPS218 |
| Notes: | Meeting Abstract: TPS218 -- Source: Wos |
